kongre.net
Welcome to kongre.net

Speaker

Stephanie Tagliatela

Co-Founder & Chief Scientific Officer, Encoded Therapeutics

Stephanie Tagliatela, Co-Founder & Chief Scientific Officer at Encoded Therapeutics, spoke at Ion Channel-Targeted Drug Development Summit (Boston, United States of America, 23–24 Sept 2026) in the session “Restoring SCN1A-Mediated Neuronal Excitability Through Cell-Selective Gene Regulation in Clinical Dravet Syndrome”.

Conferences
1
Keynotes
0
Upcoming
0

Past appearances

More speakers at Ion Channel-Targeted Drug Development Summit

  • Christopher Ahern

    Professor - Molecular Physiology & Biophysics, The University of Iowa

  • Alejandro Amador

    Vice President of R&D and Operations, Navega Therapeutics

  • Bruce Bean

    Professor of Neurobiology, Harvard Medical School

  • Gulayse Dunn

    Senior Principal Scientist, Novartis

  • Dan Elbaum

    Chief Scientific Officer, QurAlis Corp.

  • Jim Ellis

    Chief Scientific Officer, Nocion Therapeutics, Inc.

See all 20 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Stephanie Tagliatela, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].